Antazoline mesilate or mesylate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H19N3.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KU470J7TY6. European Medicines Agency schedules antazoline mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00540MIG. The term antazoline mesilate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule antazoline mesylate under HS 29332990. As of Q4 2014, ANTAZOLINE MESYLATE remains US FDA's Preferred Term for this commodity. Antazoline mesylate bears US NLM identifiers UMLS ID C0771474 and NCI Concept Code C95311. SMILES: CS(=O)(=O)O.C1CCC(CC1)CN(CC2=NCCN2)C3CCCCC3.